Thompson Peter A. bought SION

February 10, 2025 · Form 4 insider transaction

Thompson Peter A. bought 550,000 shares of Sionna Therapeutics, Inc. at $18.00 per share, a transaction worth $9.90M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
550,000
Price
$18.00
Total value
$9.90M
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 10, 2025
Filing dateFebruary 10, 2025
Shares owned after3,704,959
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects shares purchased in the Issuer's initial public offering.; The securities are held of record by OrbiMed Private Investments VIII, LP ("OPI VIII"). OrbiMed Capital GP VIII LLC ("GP VIII") is the general partner of OPI VIII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VIII. By virtue of such relationships, GP VIII and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VIII and as a result may be deemed to have beneficial ownership of such shares. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VIII.; Each of OrbiMed Advisors, GP VIII and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose.

View the original Form 4 on SEC EDGAR